CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Growth inhibition depends on tyrosine 367 and glutamine 370 of the IL-9R. BW5147 cells were transfected with the following receptors: hIL-9R (wild-type); mut1 (Tyr-367 to Phe, abrogates STAT activation); mut6 (Leu-368 to Arg, results in the preferential activation of STAT1 and STAT3); and mut7 (Gln-370 to Leu, preferential activation of STAT5) (10) . Clones expressing a similar level of receptor were stimulated with hIL-9. After 3 days, proliferation was evaluated by measuring [3H]thymidine incorporation. A representative experiment is shown, with SDs (bars) calculated from triplicate cultures.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation